Aminocaproic acid (aminocaproic acid) tablets 0.5 №20

$7.00

Manufacturer: Ukraine

Purpose: Inhibits fibrinolysis for bleeding disorders and surgical procedures.

SKU: MED56409 Category:

Description

Aminocaproic Acid Tablets

Composition:

Each tablet contains 0.5g of Aminocaproic Acid.

Mechanism of Action:

Aminocaproic acid inhibits the breakdown of blood clots by preventing the activation of plasminogen, thus promoting hemostasis and reducing bleeding episodes.

Pharmacological Properties:

Upon oral administration, Aminocaproic Acid is rapidly absorbed and acts as an antifibrinolytic agent by stabilizing blood clots.

Indications for Use:

Aminocaproic Acid tablets are indicated for the treatment of excessive bleeding resulting from surgical procedures, trauma, or specific medical conditions.

Contraindications:

Avoid using Aminocaproic Acid tablets if you have a history of hypersensitivity to the drug or a predisposition to blood clots.

Side Effects:

Common side effects may include nausea, vomiting, diarrhea, or dizziness. If you experience any severe side effects, contact your healthcare provider immediately.

Usage Instructions:

The typical dosage is 1-2 tablets taken orally 3-4 times a day. Adhere to the prescribed dosage and do not exceed the recommended amount.

Advantages Over Analogues:

Aminocaproic Acid has demonstrated comparable efficacy to other antifibrinolytic agents in controlling bleeding episodes, with a well-tolerated safety profile.

Suitable Patient Groups:

Aminocaproic Acid can be used in various patient populations, including children and the elderly, under appropriate medical supervision.

Storage and Shelf Life:

Store Aminocaproic Acid tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use expired medication.

Packaging Description:

Aminocaproic Acid tablets are available in a package containing 20 tablets of 0.5g each.

Clinical Evidence:

Aminocaproic Acid has been shown to effectively reduce bleeding during surgical procedures and in patients with bleeding disorders. Clinical trials have supported its use in various clinical scenarios.